Paula Cloghessy
Keine laufenden Positionen mehr
Vermögen: 33 943 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Paula Cloghessy
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 22 | |
Joule Unlimited Technologies, Inc.
 Joule Unlimited Technologies, Inc. Industrial SpecialtiesProcess Industries Joule Unlimited Technologies, Inc. produces renewable fuels and chemicals. It offers a technology platform for liquid fuel from the Sun. The company was founded by Noubar B. Afeyan in 2007 and is headquartered in Bedford, MA.
13
| Extinct | Industrial Specialties | 13 |
| Public Company | Biotechnology | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Paula Cloghessy
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| IKENA ONCOLOGY, INC. | Biotechnology | Chairman Director/Board Member Chairman Director/Board Member | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| AXCA HEALPAR | Biotechnology | Founder Director/Board Member Corporate Officer/Principal | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Worcester Polytechnic Institute | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| CELGENE | Biotechnology | Sales & Marketing Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Chairman Director/Board Member | |
| DNIB UNWIND INC | Biotechnology | Chairman Corporate Officer/Principal | |
Ohana Biosciences, Inc.
 Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
The Russian Union of Industrialists & Entrepreneurs
 The Russian Union of Industrialists & Entrepreneurs Miscellaneous Commercial ServicesCommercial Services The Russian Union of Industrialists & Entrepreneurs operates as a non-political organization to protect the interests of industry. The company is based in Moscow, Russian Federation and has subsidiaries in the Russian Federation. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Upstream Bio, Inc.
 Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Private Equity Investor | |
| Norwegian School of Economics & Business Administration | College/University | Graduate Degree Graduate Degree | |
| CHIMERIX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| NEON THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Human Resources Officer Corporate Officer/Principal | |
| Boston University | College/University | Undergraduate Degree Doctorate Degree | |
Agrinos AS
 Agrinos AS Chemicals: AgriculturalProcess Industries Agrinos AS engages in the development, production, and trade of biological crop inputs. Its products include iNvigorate, B-Sure, and Agrinos 5-0-0. The firm focuses on core crops such as corn, potatoes, soybeans, sugarcanes, tomatoes, and wheat; and regional crops such as verries, citrus and fruit trees, coffee, cotton, forage, leafy greens, and vegetables. The company was founded by Kjetil Langland Bøhn, Karl Reiner Fick Rochin, and Aaron Powers in 2009 and is headquartered in Oslo, Norway. | Chemicals: Agricultural | Chief Executive Officer Chief Executive Officer | |
| University of Virginia | College/University | Corporate Officer/Principal Graduate Degree | |
| INTELLIA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| Sail Bio, Inc. | Director/Board Member Chief Executive Officer | ||
| Harvard Medical School | College/University | Corporate Officer/Principal Graduate Degree | |
| INSEAD | College/University | Undergraduate Degree Masters Business Admin | |
Navitor Pharmaceuticals, Inc.
 Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| OMEGA THERAPEUTICS, INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer | |
| University of Michigan | College/University | Doctorate Degree | |
SYSTEMIQ Ltd.
 SYSTEMIQ Ltd. Investment ManagersFinance SystemIQ Ltd (SystemIQ ) is a venture capital firm founded by Martin Stuchtey and Jeremy Oppenheim in 2016. The firm Headquartered in United Kingdom. | Investment Managers | Consultant / Advisor | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
River Vision Development Corp.
 River Vision Development Corp. BiotechnologyHealth Technology River Vision Development Corp. develops novel protein therapies. The firm provides therapy for the treatment of graves orbitopathy which is a condition in which an autoimmune response is mounted against tissues behind the eye, causing inflammation, tissue proliferation and excess production of extracellular matrix. The company was founded in 2011 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Corporate Officer/Principal | |
| Edge Global LLC | Founder | ||
| TESARO INC | Pharmaceuticals: Major | Sales & Marketing | |
Center for American Progress
 Center for American Progress Miscellaneous Commercial ServicesCommercial Services The Center for American Progress is an advocacy organization. The non-profit company is based in Washington. The American company was founded by John D. Podesta. Patrick Gaspard has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Founder | |
| DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Abingworth Management, Inc.
 Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Investment Managers | Private Equity Investor |
Statistik
International
| Vereinigte Staaten | 43 |
| Norwegen | 4 |
| Russland | 2 |
| Frankreich | 2 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 9 |
| Finance | 6 |
| Commercial Services | 5 |
| Producer Manufacturing | 3 |
Operativ
| Director/Board Member | 217 |
| Corporate Officer/Principal | 89 |
| Independent Dir/Board Member | 69 |
| Chairman | 52 |
| Founder | 44 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jean-Francois Formela | 47 |
| Daniel Lynch | 32 |
| David Berry | 31 |
| Anatoliy Borisovich Chubays | 29 |
| Caroline Dorsa | 27 |
| Ruben Karlenovich Vardanian | 26 |
| Ronald Renaud | 24 |
| Owen Hughes | 23 |
| Brian Gallagher | 20 |
| Grégory Behar | 20 |
| Raffi Mardirosian | 18 |
| Claire Fraser-Liggett | 13 |
| Robert Meyer | 13 |
| E. Sutherland | 12 |
| George Demetri | 12 |
- Börse
- Insiders
- Paula Cloghessy
- Unternehmensverbindungen
